Search

everythinglearnresearchcommunity

for

Search:↓

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Nilotinib can cause keratosis pilaris, a skin condition.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Two impurities in finasteride were identified and characterized as cyclohexyl and phenyl analogs.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

The process effectively regenerates the Pd/C catalyst for finasteride synthesis.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.